Oncopeptides AB

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 44.36% vs 34.34% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -3.46% vs 27.22% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.20",
          "val2": "13.30",
          "chgp": "44.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-57.50",
          "val2": "-60.70",
          "chgp": "5.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.60",
          "val2": "0.80",
          "chgp": "725.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-62.80",
          "val2": "-60.70",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,994.40%",
          "val2": "-4,573.40%",
          "chgp": "157.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -10.23% vs 319.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -14.25% vs 26.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.60",
          "val2": "35.20",
          "chgp": "-10.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-279.70",
          "val2": "-248.10",
          "chgp": "-12.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.70",
          "val2": "5.80",
          "chgp": "118.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-284.60",
          "val2": "-249.10",
          "chgp": "-14.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9,146.90%",
          "val2": "-7,357.40%",
          "chgp": "-178.95%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

19.20

13.30

44.36%

Operating Profit (PBDIT) excl Other Income

-57.50

-60.70

5.27%

Interest

6.60

0.80

725.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-62.80

-60.70

-3.46%

Operating Profit Margin (Excl OI)

-2,994.40%

-4,573.40%

157.90%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 44.36% vs 34.34% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -3.46% vs 27.22% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

31.60

35.20

-10.23%

Operating Profit (PBDIT) excl Other Income

-279.70

-248.10

-12.74%

Interest

12.70

5.80

118.97%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-284.60

-249.10

-14.25%

Operating Profit Margin (Excl OI)

-9,146.90%

-7,357.40%

-178.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -10.23% vs 319.05% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -14.25% vs 26.30% in Dec 2023

All Annual Results